Beryl Drugs Ltd. benchmarking: Performance to industry peers

Financial

	Beryl Drugs	Hind Bio Science	Colinz Laboratories
Operational Metrics
Financials
5 yr Average ROE	5.44 %	3.66 %	4.71 %
5yr average Equity Multiplier	2.12	3.76	1.29
5yr Average Asset Turnover Ratio	1.19	0.25	0.64
5yr Avg Net Profit Margin	1.13 %	-39.56 %	5.84 %
Price to Book	1.06	10.47	1.1
P/E	797.43	61.58	21.61
5yr Avg Cash Conversion Cycle	-589.78 Days	197.57 Days	-11.59 Days
Inventory Days	36.09 Days	0.0	56.66 Days
Days Receivable	112.55 Days	198.39 Days	42.5 Days
Days Payable	964.25 Days	104.32 Days	89.1 Days
5yr Average Interest Coverage Ratio	1.91	-32.49	11.55
5yr Avg ROCE	7.2 %	-14.28 %	6.71 %
5yr Avg Operating Profit Margin	6.72 %	-38.68 %	7.54 %
5 yr average Debt to Equity	0.59	2.68	0.07
5yr CAGR Net Profit	19.3 %	n/a	18.95 %
5yr Average Return on Assets	1.98 %	-8.2 %	3.68 %
Shareholdings
Promoter Holding	27.48 %	12.19 %	66.0 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.1 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0